Ileal bile acid transport inhibitors - A new future in treatment of cholestatic diseases.

 0 Người đánh giá. Xếp hạng trung bình 0

Tác giả: Paula Casajús Pelegay, Ruth García Romero, Enrique Medina Benítez, Ignacio Ros Arnal, Amaia Salinas Uhalte

Ngôn ngữ: eng

Ký hiệu phân loại: 069.134 Representations of museum objects

Thông tin xuất bản: Spain : Revista espanola de enfermedades digestivas , 2025

Mô tả vật lý:

Bộ sưu tập: NCBI

ID: 213799

We present a 14-year-old male with PFIC1 who required double liver transplant at five years old. Subsequently, liver function normalized, nevertheless, bowel habits and intestinal malabsorption worsened (10-12 daily and nocturnal stools, Bristol 6-7), with severe dehydration that required multiple hospitalizations, associating malnutrition and failure to thrive that required daily home parenteral nutrition(PN). At 14 years old, Odevixibat (40 mcg/kg/day) was initiated, leading to a marked improvement in bowel habits by the second day (1-2 daily stools, Bristol 2) and progressive weight gain, which allowed after 40 days of treatment discontinue PN following seven years.
Tạo bộ sưu tập với mã QR

THƯ VIỆN - TRƯỜNG ĐẠI HỌC CÔNG NGHỆ TP.HCM

ĐT: (028) 36225755 | Email: tt.thuvien@hutech.edu.vn

Copyright @2024 THƯ VIỆN HUTECH